We are thrilled to announce that the the University Clinical Center of the Medical University of Warsaw has joined the ADONIS-PCI clinical trial as a new study site. As the proud sponsor of this groundbreaking research endeavor, we are excited about the university's involvement in advancing cardiovascular medicine and improving patient outcomes. The ADONIS-PCI clinical trial is a global, multi-center study designed to evaluate the safety and efficacy of a novel treatment for patients with coronary artery disease (CAD) who require percutaneous coronary intervention (PCI). By joining forces with the Medical University of Warsaw, renowned for its expertise and commitment to medical excellence, we are confident that the trial will benefit from their exceptional resources, dedicated researchers, and experienced healthcare professionals.